By binding to its receptor, CCR10, CCL28 can effectively recruit CCR10+ Treg cells to the tumor site, thus suppressing the functions of effector T-cells and promoting the tumor growth [44, 46]. The gene discussed is CCR10; the disease is neoplasm.